Clinical Trial Update: Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update documents the completion of a single-dose TT-034 safety and efficacy study in patients with chronic hepatitis C (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• TT-034

Snippet

Sponsor: Tacere Therapeutics, Inc. | Conditions: Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED